Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance.
Identifieur interne : 001D84 ( PubMed/Corpus ); précédent : 001D83; suivant : 001D85Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance.
Auteurs : M. Göker ; N. Devoogdt ; G. Van De Putte ; J C Schobbens ; J. Vlasselaer ; R. Van Den Broecke ; E T M. De JongeSource :
- Facts, views & vision in ObGyn [ 2032-0418 ] ; 2013.
Abstract
Breast cancer-related lymphoedema (BCRL) is a disabling complication developing after breast cancer treatment in a proportion of patients. Its impact on quality of life becomes more substantial as survival after breast cancer diagnosis increases. The incidence of BCRL following breast cancer treatment varies due to a lack of -uniform definition and measurement criteria. This review aims to determine the prevalence of BCRL following axillary lymph node dissection (ALND) as a benchmark to be used in a risk-benefit medical decision whether to proceed with ALND or not. The risk of leaving unresected non-sentinel metastatic lymph nodes with a presumed inherent risk of local recurrence will be balanced against the risk of BCRL following a potentially unnecessary ALND.
PubMed: 24753936
Links to Exploration step
pubmed:24753936Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance.</title><author><name sortKey="Goker, M" sort="Goker, M" uniqKey="Goker M" first="M" last="Göker">M. Göker</name><affiliation><nlm:affiliation>Department of Obstetrics & Gynaecology, Ziekenhuis Oost-Limburg Campus St Jan, Schiepse Bos 6, 3600 Genk, -Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Devoogdt, N" sort="Devoogdt, N" uniqKey="Devoogdt N" first="N" last="Devoogdt">N. Devoogdt</name><affiliation><nlm:affiliation>Department of Revalidation Sciences, University Hospitals Leuven, Herestraat 49 bus 7003, 3000 Leuven, Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Van De Putte, G" sort="Van De Putte, G" uniqKey="Van De Putte G" first="G" last="Van De Putte">G. Van De Putte</name><affiliation><nlm:affiliation>Department of Obstetrics & Gynaecology, Ziekenhuis Oost-Limburg Campus St Jan, Schiepse Bos 6, 3600 Genk, -Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Schobbens, J C" sort="Schobbens, J C" uniqKey="Schobbens J" first="J C" last="Schobbens">J C Schobbens</name><affiliation><nlm:affiliation>Department of Obstetrics & Gynaecology, Ziekenhuis Oost-Limburg Campus St Jan, Schiepse Bos 6, 3600 Genk, -Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Vlasselaer, J" sort="Vlasselaer, J" uniqKey="Vlasselaer J" first="J" last="Vlasselaer">J. Vlasselaer</name><affiliation><nlm:affiliation>Department of Obstetrics & Gynaecology, Ziekenhuis Oost-Limburg Campus St Jan, Schiepse Bos 6, 3600 Genk, -Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Van Den Broecke, R" sort="Van Den Broecke, R" uniqKey="Van Den Broecke R" first="R" last="Van Den Broecke">R. Van Den Broecke</name><affiliation><nlm:affiliation>Department of Obstetrics & Gynaecology, University Hospital Ghent, De Pintelaan 185, 9000 Ghent, Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="De Jonge, E T M" sort="De Jonge, E T M" uniqKey="De Jonge E" first="E T M" last="De Jonge">E T M. De Jonge</name><affiliation><nlm:affiliation>Department of Obstetrics & Gynaecology, Ziekenhuis Oost-Limburg Campus St Jan, Schiepse Bos 6, 3600 Genk, -Belgium.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:24753936</idno><idno type="pmid">24753936</idno><idno type="wicri:Area/PubMed/Corpus">001D84</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001D84</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance.</title><author><name sortKey="Goker, M" sort="Goker, M" uniqKey="Goker M" first="M" last="Göker">M. Göker</name><affiliation><nlm:affiliation>Department of Obstetrics & Gynaecology, Ziekenhuis Oost-Limburg Campus St Jan, Schiepse Bos 6, 3600 Genk, -Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Devoogdt, N" sort="Devoogdt, N" uniqKey="Devoogdt N" first="N" last="Devoogdt">N. Devoogdt</name><affiliation><nlm:affiliation>Department of Revalidation Sciences, University Hospitals Leuven, Herestraat 49 bus 7003, 3000 Leuven, Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Van De Putte, G" sort="Van De Putte, G" uniqKey="Van De Putte G" first="G" last="Van De Putte">G. Van De Putte</name><affiliation><nlm:affiliation>Department of Obstetrics & Gynaecology, Ziekenhuis Oost-Limburg Campus St Jan, Schiepse Bos 6, 3600 Genk, -Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Schobbens, J C" sort="Schobbens, J C" uniqKey="Schobbens J" first="J C" last="Schobbens">J C Schobbens</name><affiliation><nlm:affiliation>Department of Obstetrics & Gynaecology, Ziekenhuis Oost-Limburg Campus St Jan, Schiepse Bos 6, 3600 Genk, -Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Vlasselaer, J" sort="Vlasselaer, J" uniqKey="Vlasselaer J" first="J" last="Vlasselaer">J. Vlasselaer</name><affiliation><nlm:affiliation>Department of Obstetrics & Gynaecology, Ziekenhuis Oost-Limburg Campus St Jan, Schiepse Bos 6, 3600 Genk, -Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="Van Den Broecke, R" sort="Van Den Broecke, R" uniqKey="Van Den Broecke R" first="R" last="Van Den Broecke">R. Van Den Broecke</name><affiliation><nlm:affiliation>Department of Obstetrics & Gynaecology, University Hospital Ghent, De Pintelaan 185, 9000 Ghent, Belgium.</nlm:affiliation></affiliation></author><author><name sortKey="De Jonge, E T M" sort="De Jonge, E T M" uniqKey="De Jonge E" first="E T M" last="De Jonge">E T M. De Jonge</name><affiliation><nlm:affiliation>Department of Obstetrics & Gynaecology, Ziekenhuis Oost-Limburg Campus St Jan, Schiepse Bos 6, 3600 Genk, -Belgium.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Facts, views & vision in ObGyn</title><idno type="ISSN">2032-0418</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Breast cancer-related lymphoedema (BCRL) is a disabling complication developing after breast cancer treatment in a proportion of patients. Its impact on quality of life becomes more substantial as survival after breast cancer diagnosis increases. The incidence of BCRL following breast cancer treatment varies due to a lack of -uniform definition and measurement criteria. This review aims to determine the prevalence of BCRL following axillary lymph node dissection (ALND) as a benchmark to be used in a risk-benefit medical decision whether to proceed with ALND or not. The risk of leaving unresected non-sentinel metastatic lymph nodes with a presumed inherent risk of local recurrence will be balanced against the risk of BCRL following a potentially unnecessary ALND.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">24753936</PMID><DateCreated><Year>2014</Year><Month>04</Month><Day>22</Day></DateCreated><DateCompleted><Year>2014</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2032-0418</ISSN><JournalIssue CitedMedium="Print"><Volume>5</Volume><Issue>2</Issue><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>Facts, views & vision in ObGyn</Title><ISOAbbreviation>Facts Views Vis Obgyn</ISOAbbreviation></Journal><ArticleTitle>Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance.</ArticleTitle><Pagination><MedlinePgn>106-15</MedlinePgn></Pagination><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">Breast cancer-related lymphoedema (BCRL) is a disabling complication developing after breast cancer treatment in a proportion of patients. Its impact on quality of life becomes more substantial as survival after breast cancer diagnosis increases. The incidence of BCRL following breast cancer treatment varies due to a lack of -uniform definition and measurement criteria. This review aims to determine the prevalence of BCRL following axillary lymph node dissection (ALND) as a benchmark to be used in a risk-benefit medical decision whether to proceed with ALND or not. The risk of leaving unresected non-sentinel metastatic lymph nodes with a presumed inherent risk of local recurrence will be balanced against the risk of BCRL following a potentially unnecessary ALND.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Pubmed and Embase databases were searched for all publications on BCRL in order to estimate its -incidence and to decide on the most appropriate measurement method to use in clinical practice.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">51 articles were identified on BCRL incidence and measurement technique. Most studies measured BCRL based on differences in arm circumference (n = 18) or by self-reported symptoms (n = 18). The weighted average of BCRL incidence following ALND measured by self-report and circumference method was 28% and 16%, respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The importance of ALND and irradiation as part of the treatment of operable breast carcinoma is well established, but its morbidity is less well documented. We argue self-report as the most appropriate method to -establish a diagnosis of BCRL. Therefore a 28% risk of finding non-sentinel lymph node metastases in a completion ALND will be regarded as the cut-off in a medical decision to proceed with ALND.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Göker</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Obstetrics & Gynaecology, Ziekenhuis Oost-Limburg Campus St Jan, Schiepse Bos 6, 3600 Genk, -Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devoogdt</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Revalidation Sciences, University Hospitals Leuven, Herestraat 49 bus 7003, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van de Putte</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Obstetrics & Gynaecology, Ziekenhuis Oost-Limburg Campus St Jan, Schiepse Bos 6, 3600 Genk, -Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schobbens</LastName><ForeName>J C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Obstetrics & Gynaecology, Ziekenhuis Oost-Limburg Campus St Jan, Schiepse Bos 6, 3600 Genk, -Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vlasselaer</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Obstetrics & Gynaecology, Ziekenhuis Oost-Limburg Campus St Jan, Schiepse Bos 6, 3600 Genk, -Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van den Broecke</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Obstetrics & Gynaecology, University Hospital Ghent, De Pintelaan 185, 9000 Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Jonge</LastName><ForeName>E T M</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>Department of Obstetrics & Gynaecology, Ziekenhuis Oost-Limburg Campus St Jan, Schiepse Bos 6, 3600 Genk, -Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Belgium</Country><MedlineTA>Facts Views Vis Obgyn</MedlineTA><NlmUniqueID>101578773</NlmUniqueID><ISSNLinking>2032-0418</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Cancer. 1998 Dec 15;83(12 Suppl American):2776-81</RefSource><PMID Version="1">9874397</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Nov 10;26(32):5213-9</RefSource><PMID Version="1">18838709</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2009 Apr;16(4):979-88</RefSource><PMID Version="1">19194754</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Surg Oncol. 2004 Oct 1;88(1):4-7; discussion 7-8</RefSource><PMID Version="1">15384064</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2001 Jan 17;93(2):96-111</RefSource><PMID Version="1">11208879</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann R Coll Surg Engl. 2003 May;85(3):158-61</RefSource><PMID Version="1">12831486</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet. 2012 Feb 4;379(9814):432-44</RefSource><PMID Version="1">22152853</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2012 Jun;21(3):361-5</RefSource><PMID Version="1">22460058</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2001 Oct 1;92(7):1783-7</RefSource><PMID Version="1">11745250</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer Care (Engl). 1996 Mar;5(1):7-12</RefSource><PMID Version="1">8715464</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast. 2010 Dec;19(6):506-15</RefSource><PMID Version="1">20561790</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer. 1997 Feb;33(2):193-9</RefSource><PMID Version="1">9135487</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast J. 2006 Nov-Dec;12(6):536-43</RefSource><PMID Version="1">17238983</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Can Fam Physician. 2010 Dec;56(12):1277-84</RefSource><PMID Version="1">21375063</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann R Coll Surg Engl. 1992 Mar;74(2):126-9</RefSource><PMID Version="1">1567131</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Jul 20;26(21):3536-42</RefSource><PMID Version="1">18640935</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2012 Aug;19(8):2580-9</RefSource><PMID Version="1">22395997</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 2008;47(5):835-42</RefSource><PMID Version="1">18568481</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Surg. 2010 Nov;145(11):1055-63</RefSource><PMID Version="1">21079093</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nurs Res. 2003 Nov-Dec;52(6):370-9</RefSource><PMID Version="1">14639083</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2007 Mar;40(1):35-46</RefSource><PMID Version="1">17539463</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Cancer Care (Engl). 2011 Jan;20(1):77-86</RefSource><PMID Version="1">19708945</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg. 2012 Jan;255(1):116-21</RefSource><PMID Version="1">22183034</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2004 Jun;11(6):573-80</RefSource><PMID Version="1">15172932</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Surg Oncol. 2006 Sep;32(7):729-32</RefSource><PMID Version="1">16777367</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2006 May 3;98(9):599-609</RefSource><PMID Version="1">16670385</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Acta Oncol. 2000;39(3):393-7</RefSource><PMID Version="1">10987237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Nurs. 2008 Jul-Aug;31(4):302-9; quiz 310-1</RefSource><PMID Version="1">18600117</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Surg Oncol. 2002 Nov;28(7):705-10</RefSource><PMID Version="1">12431466</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Womens Health (Larchmt). 2003 Nov;12(9):921-30</RefSource><PMID Version="1">14670172</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2011 Feb 9;305(6):569-75</RefSource><PMID Version="1">21304082</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Cancer. 1992 Jul;66(1):136-8</RefSource><PMID Version="1">1637663</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Aust N Z J Surg. 2000 Jun;70(6):412-8</RefSource><PMID Version="1">10843395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):775-82</RefSource><PMID Version="1">17416770</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur J Surg Oncol. 2011 Dec;37(12):1059-63</RefSource><PMID Version="1">21937192</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg. 2010 Apr;251(4):595-600</RefSource><PMID Version="1">20195151</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2003 Aug 15;98(4):679-89</RefSource><PMID Version="1">12910510</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2013 Aug;20(8):2556-61</RefSource><PMID Version="1">23456432</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Natl Cancer Inst. 2012 Dec 19;104(24):1888-96</RefSource><PMID Version="1">23117131</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2006 Jan 1;106(1):4-16</RefSource><PMID Version="1">16329134</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Patient Educ Couns. 2007 Jun;66(3):311-8</RefSource><PMID Version="1">17331692</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2003 May;79(1):47-57</RefSource><PMID Version="1">12779081</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Oncol Nurs Forum. 2008 Jan;35(1):65-71</RefSource><PMID Version="1">18192154</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2002 Oct 15;20(20):4242-8</RefSource><PMID Version="1">12377968</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mol Cell. 2002 Dec;10(6):1262-3</RefSource><PMID Version="1">12504001</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2001 Sep 15;92(6):1368-77</RefSource><PMID Version="1">11745212</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>QJM. 2005 May;98(5):343-8</RefSource><PMID Version="1">15820971</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Med Insights Oncol. 2011 Feb 07;5:9-14</RefSource><PMID Version="1">21339859</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2009 Jan 20;27(3):390-7</RefSource><PMID Version="1">19064976</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Nurs. 2008 Jun;17(11):1450-9</RefSource><PMID Version="1">18482142</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer. 2000 Feb 1;88(3):608-14</RefSource><PMID Version="1">10649254</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Annu Rev Med. 2013;64:119-29</RefSource><PMID Version="1">23020881</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Facts Views Vis Obgyn. 2009;1(2):122-9</RefSource><PMID Version="1">25478077</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2734-46</RefSource><PMID Version="1">20978176</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Surg Oncol. 2010 Jan 1;101(1):84-91</RefSource><PMID Version="1">19924721</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg. 2012 Dec;256(6):920-4</RefSource><PMID Version="1">23154393</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Lancet Oncol. 2007 Oct;8(10):881-8</RefSource><PMID Version="1">17851130</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Lymphoedema. 2009 Apr 1;4(1):14-18</RefSource><PMID Version="1">20182653</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2009 Jul;16(7):1959-72</RefSource><PMID Version="1">19365624</PMID></CommentsCorrections></CommentsCorrectionsList><OtherID Source="NLM">PMC3987359</OtherID><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Breast cancer</Keyword><Keyword MajorTopicYN="N">axillary lymph node dissection</Keyword><Keyword MajorTopicYN="N">definition</Keyword><Keyword MajorTopicYN="N">incidence</Keyword><Keyword MajorTopicYN="N">lymphoedema</Keyword><Keyword MajorTopicYN="N">prevalence</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24753936</ArticleId><ArticleId IdType="pmc">PMC3987359</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D84 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001D84 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:24753936
|texte= Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:24753936" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |